cmAngio® vs OMRON VitalSight
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your practice aims to proactively identify early indicators of cardiovascular risk in women during routine mammography screenings. This AI-powered tool leverages existing mammogram images to detect Breast Arterial Calcifications (BAC), providing valuable insights for cardiovascular health assessment without requiring additional patient procedures or radiation exposure.
View cmAngio® →Choose OMRON VitalSight if…
Choose OMRON VitalSight if your practice requires a comprehensive remote patient monitoring solution for managing patients with diagnosed hypertension. This service provides connected at-home blood pressure monitors that securely integrate data directly into EHRs, enabling continuous oversight, automatic alerts for out-of-range readings, and improved patient engagement in their hypertension management.
View OMRON VitalSight →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | OMRON VitalSight |
|---|---|---|
| Pricing | Paid, out-of-pocket | Reimbursement-based |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | Cloud-based (physician dashboard) with at-home patient devices. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cmAngio®cmAngiou00ae (Tool A) offers quick and easy installation (less than an hour) and is compatible with any DICOM-compliant viewer, ensuring seamless integration into existing radiology workflows. While OMRON VitalSight (Tool B) prioritizes patient usability with pre-set devices, cmAngiou00ae's low friction for clinical IT and direct integration into a physician's existing workflow gives it a slight edge for the healthcare provider.
Clinical Value
OMRON VitalSightOMRON VitalSight (Tool B) provides direct and active management of hypertension, a prevalent chronic condition, with real-time data and automatic notifications for out-of-range readings, directly impacting patient outcomes. While cmAngiou00ae (Tool A) offers valuable insights for cardiovascular risk assessment from existing mammography data, VitalSight's focus on ongoing disease management and proactive intervention gives it a stronger immediate clinical value.
Pricing & Value
OMRON VitalSightOMRON VitalSight (Tool B) has a transparent, reimbursement-based pricing model, with little to no cost for patients (depending on coverage) and no setup or device costs for physicians, making it financially accessible. In contrast, cmAngiou00ae (Tool A) has undisclosed pricing, making it difficult to assess its value proposition without direct vendor contact.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA-compliant, and cloud-based with Business Associate Agreements (BAAs). cmAngiou00ae (Tool A) integrates seamlessly into existing radiology IT infrastructure, while OMRON VitalSight (Tool B) offers robust EHR/EMR integration and secure data sharing, both critical for large-scale healthcare operations.
Innovation
cmAngio®cmAngiou00ae (Tool A) showcases greater innovation by applying AI to existing mammography images to detect Breast Arterial Calcifications (BAC), repurposing a routine breast cancer screening for novel cardiovascular risk assessment without additional procedures or radiation. While OMRON VitalSight (Tool B) innovates in remote patient monitoring delivery, cmAngiou00ae's approach represents a more transformative application of AI in leveraging existing data for new clinical insights.
Support & Docs
OMRON VitalSightOMRON VitalSight (Tool B) explicitly mentions a dedicated support team for both physicians and patients, along with training and onboarding for practices, indicating a comprehensive support structure. CureMetrix (Tool A) provides less specific information on support, primarily directing users to a general contact form and resources like white papers, making VitalSight's support offering appear more robust and clearly defined.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | OMRON VitalSight |
|---|---|---|
| Name | cmAngiou00ae | OMRON VitalSight |
| Primary Function | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. | Remote patient monitoring service for US physicians, offering connected blood pressure monitors and data hubs that securely integrate with EHRs to manage hypertension and improve patient outcomes. |
| Company | CureMetrix | OMRON Healthcare |
| Key Capabilities | AI-based detection of Breast Arterial Calcifications (BAC); Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams; Provides visualization of BAC location on a scorecard. | Remote blood pressure monitoring; Connected blood pressure monitor and data hub kit; EHR/EMR integration or VitalSight Dashboard access; Automatic notifications for out-of-range readings. |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and OMRON VitalSight.